Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.
Twitter handle: @jeffmason1
The Trump administration on Thursday proposed changes to Medicare drug plans including limits on opioid prescriptions and rules aimed at reducing drug costs for seniors, such as requiring health insurers to pass on discounts to consumers.
Tighter blood pressure guidelines from U.S. heart organizations mean millions more people need to make lifestyle changes, or start taking medication, in order to avoid cardiovascular problems.
Nov 13 Tighter blood pressure guidelines from U.S. heart organizations mean millions more people need to make lifestyle changes, or start taking medication, in order to avoid cardiovascular problems.
Gilead Sciences Inc posted better-than-expected third-quarter profit on Thursday, but shares fell after hours as use of its flagship hepatitis C drugs waned further and the company said it expects to feel the full impact of more competition in the current quarter.
Oct 26 Gilead Sciences Inc reported lower third-quarter profits on Thursday as use of its flagship hepatitis C drugs continued to wane, but the results beat Wall Street estimates due to lower costs.
Bristol-Myers Squibb Co reported a 7 percent increase in third-quarter revenue as sales of key drugs met Wall Street expectations, but earnings fell short due to higher costs and an inventory write-off, sending shares down 4 percent.
Oct 26 Bristol-Myers Squibb Co reported a 7 percent increase in third-quarter revenue as sales of key drugs met Wall Street expectations, but adjusted earnings fell slightly short due to an inventory write-off.
Vertex Pharmaceuticals Inc raised its outlook for full-year sales of its cystic fibrosis drugs as it released quarterly earnings on Wednesday, but the company reported disappointing results from two clinical trials and its shares tumbled 3 percent in after-hours trade.
Drugmaker Merck & Co Inc , moving to a new sales team structure in the United States, plans to cut 1,800 sales positions, while adding 960 jobs to a new chronic care sales force, the company said on Friday.
Amid a growing U.S. opioid addiction, health insurer Cigna Corp will stop covering OxyContin, the opioid painkiller sold by Purdue Pharma LP, as of Jan. 1 and will instead cover an equivalent with a formulation less vulnerable to abuse, the company said on Wednesday.
- Gold: PRECIOUS-Gold at one-month top on weak dollar, uncertainty over Trump tax bill
- Oil Report: Driverless cars set for UK budget boost-finance ministry
- British Pound Report: Sterling trims early gains as Brexit nervousness sets in
- US Dollar Report: FOREX-Dollar weak on worries over U.S. tax reform outlook, Mueller probe